T湿:

Fizza Zulfiqar1, Moazzam Shahzad2, Muhammad Kashif Amin1

  • 1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, United States; Mikael Rayaan Foundation Global Transplantation and Cellular Therapy Consortium, Kansas City, Kansas, United States.

Transplant immunology
|October 23, 2024
PubMed
概括

化学抗原受体 (CAR-T) 疗法对风湿病具有前景,大多数患者出现症状改善和疾病标志物减少. 需要进一步的试验来确认长期的安全性和有效性.